Salloway S, Pain A, Lee E, Papka M, et al. TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease. Alzheimers Dement 2025;21:e70293.
PMID: 40390253